David Holveck News
Most Popular David Holveck Story
Endo Pharma CEO plots new round of deals
Over the past year Endo's new CEO, David Holveck (photo), has been steadily shifting the company's focus from pain management to new therapeutic arenas like oncology, doing $900 million worth of Read more...
Latest Headlines
- November 30, 2009
- April 8, 2008
- March 13, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
